by Nicole Overmars | Jan 19, 2022 | Press Releases
AALBORG, Denmark – We are thrilled to announce that 2N Pharma will be a showcase presenter at BioSeed 2022. 2N Pharma will attend BioSeed, OBN’s Early-Stage Life Science Investment Event. The event takes place in London on January 25. Chair Alex Leech, CEO Preben...
by Nicole Overmars | Jan 5, 2022 | Press Releases
AALBORG, Denmark – CEO and Co-Founder Preben Bruun-Nyzell from 2N Pharma will participate in BIO Partnering during the 40th Annual J.P. Morgan Healthcare Conference, held virtually, from January 10-14. About 2N Pharma2N Pharma is a small biotech...
by Nicole Overmars | Dec 23, 2021 | Press Releases
2N Pharma wishes you and your loved ones Season’s Greetings and a prosperous New Year. As the New Year is drawing near, we want to use the opportunity to highlight some of the events of last year in video form. For instance, our board of directors and team...
by Nicole Overmars | Dec 12, 2021 | Press Releases
ALS/MND researchers from around the world convened virtually from December 7-10. The aim is to share knowledge and learn about the most recent advances in the field at the 32nd International Symposium on ALS/MND. John, Anne, and Lisa also attended the...
by Nicole Overmars | Jun 22, 2021 | Advisors & Collaborators
Alasdair Naylor is a pharmacologist with over 30 years of experience. He gained his expertise at Pfizer and Solace Pharmaceuticals. More, he is the founder of a new start-up pain company, Sevenless Therapeutics. In addition to holding senior positions in these...
Recent Comments